OxFORD Asset Management LLP acquired a new stake in Henry Schein, Inc. (NASDAQ:HSIC) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 35,150 shares of the company’s stock, valued at approximately $2,845,000.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Intrust Bank NA increased its holdings in Henry Schein by 1.1% during the 2nd quarter. Intrust Bank NA now owns 1,219 shares of the company’s stock worth $223,000 after purchasing an additional 13 shares in the last quarter. Bronfman E.L. Rothschild L.P. increased its holdings in Henry Schein by 4.0% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 14,859 shares of the company’s stock worth $2,719,000 after purchasing an additional 566 shares in the last quarter. Bradley Foster & Sargent Inc. CT increased its holdings in Henry Schein by 2.1% during the 2nd quarter. Bradley Foster & Sargent Inc. CT now owns 33,106 shares of the company’s stock worth $6,059,000 after purchasing an additional 690 shares in the last quarter. Steinberg Global Asset Management increased its holdings in Henry Schein by 100.0% during the 3rd quarter. Steinberg Global Asset Management now owns 19,412 shares of the company’s stock worth $1,592,000 after purchasing an additional 9,706 shares in the last quarter. Finally, Comerica Bank increased its holdings in Henry Schein by 10.6% during the 2nd quarter. Comerica Bank now owns 21,833 shares of the company’s stock worth $4,054,000 after purchasing an additional 2,101 shares in the last quarter. Institutional investors and hedge funds own 91.75% of the company’s stock.
In related news, Director Barry J. Alperin sold 5,796 shares of the firm’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $70.76, for a total value of $410,124.96. Following the completion of the sale, the director now directly owns 48,172 shares in the company, valued at approximately $3,408,650.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.19% of the company’s stock.
A number of equities analysts have issued reports on HSIC shares. Credit Suisse Group reiterated a “hold” rating and set a $87.50 target price on shares of Henry Schein in a report on Tuesday, August 29th. Piper Jaffray Companies upgraded Henry Schein from a “neutral” rating to an “overweight” rating in a report on Friday, September 15th. Craig Hallum upgraded Henry Schein from a “hold” rating to a “buy” rating in a report on Tuesday, November 7th. Zacks Investment Research cut Henry Schein from a “hold” rating to a “sell” rating in a report on Monday, November 13th. Finally, Morgan Stanley began coverage on Henry Schein in a report on Thursday, September 21st. They issued an “equal weight” rating and a $88.00 price objective for the company. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $87.79.
Henry Schein, Inc. (NASDAQ HSIC) opened at $67.90 on Monday. The firm has a market capitalization of $10,657.18, a PE ratio of 19.05, a PEG ratio of 1.91 and a beta of 0.99. The company has a quick ratio of 0.86, a current ratio of 1.55 and a debt-to-equity ratio of 0.30. Henry Schein, Inc. has a 1-year low of $65.28 and a 1-year high of $93.50.
Henry Schein (NASDAQ:HSIC) last issued its earnings results on Monday, November 6th. The company reported $0.87 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.90 by ($0.03). Henry Schein had a net margin of 4.52% and a return on equity of 19.71%. The firm had revenue of $3.16 billion during the quarter, compared to analyst estimates of $3.05 billion. During the same quarter last year, the business posted $0.84 earnings per share. The company’s revenue for the quarter was up 10.3% on a year-over-year basis. sell-side analysts expect that Henry Schein, Inc. will post 3.6 earnings per share for the current fiscal year.
Henry Schein announced that its Board of Directors has initiated a stock buyback plan on Monday, September 18th that permits the company to repurchase $400.00 million in shares. This repurchase authorization permits the company to purchase up to 6.3% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board believes its stock is undervalued.
ILLEGAL ACTIVITY NOTICE: This report was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another website, it was stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this report can be accessed at https://www.dispatchtribunal.com/2017/12/11/oxford-asset-management-llp-takes-2-85-million-position-in-henry-schein-inc-hsic.html.
Henry Schein Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.